GTR Home > Tests > Search results - C1868633[DISCUI]

Apply filters

Showing tests for all 1219 conditions

Compare labs

Your search term can be found in tests with a total of 1219 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states
More locations

GTR test search results for C1868633[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 58 tests for 1219 conditions in 26 labs

CRapid microarray (CGH and SNP)

Lab: Allele Diagnostics Spokane, Washington, United States
Test targets
Methods
  • H Detection of homozygosity
  • D Deletion/duplication analysis
  • H Detection of homozygosity
Total conditions (247)
Total targets (231)

CSDHD-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome

Lab: (AC) Atlanta Center: Medical Neurogenetics, LLC. Atlanta, Georgia, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CHereditary Pheochromocytoma and Paraganglioma Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (14)

CSDHD, SDHB, SDHC. MLPA testing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • D Deletion/duplication analysis

CSDHB, SDHD, SDHC. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CSDHD. Complete sequencing

Lab: Instituto de Medicina Genomica Paterna, Comunidad Valenciana, Spain
Test targets
Methods
  • C Sequence analysis of the entire coding region

CRenal Cancer NextGen Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (26)
Total targets (19)

CHereditary Paraganglioma-Pheochromocytoma Syndrome Sequencing Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (12)
Total targets (12)

CHereditary Paraganglioma-Pheochromocytoma Syndrome via the SDHD Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CnucSEEK® Comprehensive Sequence Analysis Of The Nuclear Mitochondrial Exome

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (560)
Total targets (420)

CHereditary Paraganglioma-Pheochromocytoma (SDHD) Sequencing and Deletion/Duplication

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CSDHD

Lab: Fulgent Clinical Diagnostics Lab Fulgent Diagnostics Temple City, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (133)

CPARAGANGLIOMA-PHEOCHROMOCYTOMA

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (11)

CInvitae Sarcoma Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (27)
Total targets (30)

CInvitae Renal/Urinary Tract Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (38)
Total targets (29)

CInvitae Paraganglioma-Pheochromocytoma Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (18)
Total targets (14)

CInvitae Thyroid Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (32)
Total targets (11)

CInvitae Multi-Cancer Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (139)
Total targets (79)

CInvitae Hereditary Paraganglioma-Pheochromocytoma Panel

Lab: Invitae San Francisco, California, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (10)
Total targets (13)

Showing 1 to 20 of 58 tests for 1219 conditions in 26 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.